Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT05389267
PHASE1/PHASE2
Safety Assessment of T4090 Eye Drops in Ocular Hypertensive or Glaucomatous Patients.
Sponsor: Laboratoires Thea
View on ClinicalTrials.gov
Summary
The study purpose is to evaluate the safety of T4090.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2022-07-05
Completion Date
2024-12-31
Last Updated
2024-02-07
Healthy Volunteers
No
Conditions
Interventions
DRUG
Kinezodianone R hydrochloride
Eyedrops
DRUG
Placebo
Placebo
Locations (1)
Dr EL-HARAZI
Glendale, California, United States